Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Ono Pharmaceutical Co., Ltd.

OPHLY•PNK
Healthcare
Drug Manufacturers - General
$5.59
$0.03(0.46%)
U.S. Market opens in 8h 20m

Ono Pharmaceutical Co., Ltd. (OPHLY) Stock Overview

Explore Ono Pharmaceutical Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.9B
P/E Ratio19.21
EPS (TTM)$0.24
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$5.81
3 Months$6.80
1 Year Target$4.92

OPHLY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ono Pharmaceutical Co., Ltd. (OPHLY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 73.21, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $4.92.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.21 and a market capitalization of 7.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.37%
5-Day Change
1.55%
1-Month Change
16.35%
3-Month Change
27.51%
6-Month Change
49.73%
Year-to-Date (YTD) Change
22.75%
1-Year Change
64.75%
3-Year Change
-18.23%
5-Year Change
-42.06%
All-Time (Max) Change
50.09%

Contact Information

https://www.ono-pharma.com
81 6 6263 5670
8-2, Kyutaromachi 1-chome, Osaka, NaN, 541-8564

Company Facts

38,530 Employees
IPO DateOct 2, 2012
CountryJP
Actively Trading

Frequently Asked Questions